We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BARR GETS RIGHTS TO MARKET GENERIC ACTIQ CANCER PAIN DRUG
BARR GETS RIGHTS TO MARKET GENERIC ACTIQ CANCER PAIN DRUG
August 12, 2004
Drugmaker Cephalon has granted generic firm Barr Pharmaceutical a license to manufacture and market a generic version of Cephalon’s cancer pain treatment Actiq, Barr said.